 |
|
Detection of Paternally Inherited Fetal Point Mutations for  -Thalassemia Using Size-Fractionated Cell-Free DNA in Maternal Plasma
Ying Li, PhD;
Edoardo Di Naro, MD;
Angeloantonio Vitucci, MD;
Bernhard Zimmermann, PhD;
Wolfgang Holzgreve, MD;
Sinuhe Hahn, PhD
JAMA. 2005;293:843-849.
Context Currently, fetal point mutations cannot be reliably analyzed from circulatory fetal DNA in maternal plasma, due to the predominance of maternal DNA sequences. However, analysis of circulatory fetal DNA sequences in maternal plasma have been shown to selectively enrich for fetal DNA molecules on the basis of a smaller molecular size than maternal DNA.
Objective To examine the prenatal analysis of 4 common  -thalassemia point mutations: IVSI-1, IVSI-6, IVSI-110, and codon 39.
Design, Setting, and Patients A total of 32 maternal blood samples were collected at 10 to 12 weeks of gestation (mean, 10.7 weeks) between February 15, 2003, and February 25, 2004, in Bari, Italy, from women with risk for -thalassemia in their newborns immediately prior to chorionic villous sampling. Samples in which the father and mother did not carry the same mutation were examined. Circulatory DNA was size-fractionated by gel electrophoresis and polymerase chain reaction (PCR) amplified with a peptide-nucleic-acid clamp, which suppresses amplification of the normal maternal allele. Presence of the paternal mutant allele was detected by allele-specific real-time PCR.
Main Outcome Measure Detection of paternally inherited -globin gene point mutations.
Results Presence or absence of the paternal mutant allele was correctly determined in 6 (86%) of 7 cases with the IVSI-1 mutation, 4 (100%) of 4 with the IVSI-6 mutation, 5 (100%) of 5 with the IVSI-110 mutation, and 13 (81%) of 16 with the codon 39 mutation. One false-positive test result was scored for the IVSI-1 mutation. Two cases with the codon 39 mutation were classified as uncertain and 1 case was excluded due to lack of a diagnostic test result at the time of analysis. These results yielded an overall sensitivity of 100% and specificity of 93.8%, with classified cases removed.
Conclusion Our recently described technique of the size-fractionation of circulatory DNA in maternal plasma may be potentially useful for the noninvasive prenatal determination of fetal point mutations.
Author Affiliations: Laboratory for Prenatal Medicine, University Women’s Hospital/Department of Research, University Hospital, Basel, Switzerland (Drs Li, Zimmermann, Holzgreve, and Hahn); and Department of Obstetrics and Gynecology (Dr Di Naro) and Division of Hematology II (Dr Vitucci), University of Bari, Bari, Italy.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Microfluidics Digital PCR Reveals a Higher than Expected Fraction of Fetal DNA in Maternal Plasma
Lun et al.
Clin. Chem. 2008;54:1664-1672.
ABSTRACT
| FULL TEXT
Peptide-nucleic acid-mediated enriched polymerase chain reaction as a key point for non-invasive prenatal diagnosis of {beta}-thalassemia
Galbiati et al.
haematol 2008;93:610-614.
ABSTRACT
| FULL TEXT
Noninvasive Prenatal Diagnosis of Fetal Chromosomal Aneuploidies by Maternal Plasma Nucleic Acid Analysis
Dennis Lo and Chiu
Clin. Chem. 2008;54:461-466.
ABSTRACT
| FULL TEXT
Mass Spectrometry Based Detection of Hemoglobin E Mutation by Allele-Specific Base Extension Reaction
Tsang et al.
Clin. Chem. 2007;53:2205-2209.
ABSTRACT
| FULL TEXT
Cell-Free Fetal DNA in Amniotic Fluid: Unique Fragmentation Signatures in Euploid and Aneuploid Fetuses
Lapaire et al.
Clin. Chem. 2007;53:405-411.
ABSTRACT
| FULL TEXT
Quantitation of fetal DNA in maternal serum during the first trimester of pregnancy by the use of a DAZ repetitive probe
Stanghellini et al.
Mol Hum Reprod 2006;12:587-591.
ABSTRACT
| FULL TEXT
Investigation of the Genomic Representation of Plasma DNA in Pregnant Women by Comparative Genomic Hybridization Analysis: A Feasibility Study
Chan et al.
Clin. Chem. 2005;51:2398-2401.
FULL TEXT
Use of an Automated Method Improves the Yield and Quality of Cell-Free Fetal DNA Extracted from Maternal Plasma
Huang et al.
Clin. Chem. 2005;51:2419-2420.
FULL TEXT
Ready Detection of Donor-Specific Single-Nucleotide Polymorphisms in the Urine of Renal Transplant Recipients by Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry
Li et al.
Clin. Chem. 2005;51:1903-1904.
FULL TEXT
Medical Applications of Biotechnology
Fontanarosa and DeAngelis
JAMA 2005;293:866-867.
FULL TEXT
|
